aluates Reports

$ 0.0

Automative

Global Gene Editing Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-32W3031

Global Gene Editing Market Size Status and Forecast 2022 2028

BUY CHAPTERS

Global Gene Editing Market Research Report 2024

Code: QYRE-Auto-32W3031

Report

January 2024

Pages:99

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Thermo Fisher Scientific

Merck

Horizon Discovery

Sangamo BioSciences

Integrated DNA Technologies

Lonza

New England Biolabs

Transposagen Biopharmaceuticals

Editas Medicine

CRISPR Therapeutics

RGen Solutions

Sigma-aldrich

GeneCopoeia

Genscript Biotech

Origene Technologies

Gene Editing Market Size

The global Gene Editing market was valued at US$ 3093.1 million in 2023 and is anticipated to reach US$ 5441.3 million by 2030, witnessing a CAGR of 7.9% during the forecast period 2024-2030.

Gene Editing Market

Gemstones are elements of minerals which when polished and cut are used for making jewelry and other ornaments, as well as for decoration purposes.

Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.

This report aims to provide a comprehensive presentation of the global market for Gene Editing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Editing.

Report Scope

The Gene Editing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Editing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Gene Editing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Gene Editing Market Report

Report Metric	Details
Report Name	Gene Editing Market
Accounted market size in 2023	US$ 3093.1 million
Forecasted market size in 2030	US$ 5441.3 million
CAGR	7.9%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Zinc finger nucleases (ZFNs) Transcription Activator-Like Effector-based Nucleases (TALENs) CRISPR-Cas system
Segment by Application	Biotechnology & Pharmaceutical Companies Academic & Government Research Institutes Contract Research Organizations
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, Merck, Horizon Discovery, Sangamo BioSciences, Integrated DNA Technologies, Lonza, New England Biolabs, OriGene Technologies, Transposagen Biopharmaceuticals, Editas Medicine, CRISPR Therapeutics, RGen Solutions, Sigma-Aldrich, GeneCopoeia, Genscript Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Editing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Gene Editing Market growing?

Ans: The Gene Editing Market witnessing a CAGR of 7.9% during the forecast period 2024-2030.

What is the Gene Editing Market size in 2030?

Ans: The Gene Editing Market size in 2030 will be US$ 5441.3 million.

Who are the main players in the Gene Editing Market report?

Ans: The main players in the Gene Editing Market are Thermo Fisher Scientific, Merck, Horizon Discovery, Sangamo BioSciences, Integrated DNA Technologies, Lonza, New England Biolabs, OriGene Technologies, Transposagen Biopharmaceuticals, Editas Medicine, CRISPR Therapeutics, RGen Solutions, Sigma-Aldrich, GeneCopoeia, Genscript Biotech

What are the Application segmentation covered in the Gene Editing Market report?

Ans: The Applications covered in the Gene Editing Market report are Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, Contract Research Organizations

What are the Type segmentation covered in the Gene Editing Market report?

Ans: The Types covered in the Gene Editing Market report are Zinc finger nucleases (ZFNs), Transcription Activator-Like Effector-based Nucleases (TALENs), CRISPR-Cas system

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Gene Editing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Zinc finger nucleases (ZFNs)

1.2.3 Transcription Activator-Like Effector-based Nucleases (TALENs)

1.2.4 CRISPR-Cas system

1.3 Market by Application

1.3.1 Global Gene Editing Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Biotechnology & Pharmaceutical Companies

1.3.3 Academic & Government Research Institutes

1.3.4 Contract Research Organizations

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Gene Editing Market Perspective (2019-2030)

2.2 Gene Editing Growth Trends by Region

2.2.1 Global Gene Editing Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Gene Editing Historic Market Size by Region (2019-2024)

2.2.3 Gene Editing Forecasted Market Size by Region (2025-2030)

2.3 Gene Editing Market Dynamics

2.3.1 Gene Editing Industry Trends

2.3.2 Gene Editing Market Drivers

2.3.3 Gene Editing Market Challenges

2.3.4 Gene Editing Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Gene Editing Players by Revenue

3.1.1 Global Top Gene Editing Players by Revenue (2019-2024)

3.1.2 Global Gene Editing Revenue Market Share by Players (2019-2024)

3.2 Global Gene Editing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Gene Editing Revenue

3.4 Global Gene Editing Market Concentration Ratio

3.4.1 Global Gene Editing Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Gene Editing Revenue in 2023

3.5 Gene Editing Key Players Head office and Area Served

3.6 Key Players Gene Editing Product Solution and Service

3.7 Date of Enter into Gene Editing Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Gene Editing Breakdown Data by Type

4.1 Global Gene Editing Historic Market Size by Type (2019-2024)

4.2 Global Gene Editing Forecasted Market Size by Type (2025-2030)

5 Gene Editing Breakdown Data by Application

5.1 Global Gene Editing Historic Market Size by Application (2019-2024)

5.2 Global Gene Editing Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Gene Editing Market Size (2019-2030)

6.2 North America Gene Editing Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Gene Editing Market Size by Country (2019-2024)

6.4 North America Gene Editing Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Gene Editing Market Size (2019-2030)

7.2 Europe Gene Editing Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Gene Editing Market Size by Country (2019-2024)

7.4 Europe Gene Editing Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Gene Editing Market Size (2019-2030)

8.2 Asia-Pacific Gene Editing Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Gene Editing Market Size by Region (2019-2024)

8.4 Asia-Pacific Gene Editing Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Gene Editing Market Size (2019-2030)

9.2 Latin America Gene Editing Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Gene Editing Market Size by Country (2019-2024)

9.4 Latin America Gene Editing Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Gene Editing Market Size (2019-2030)

10.2 Middle East & Africa Gene Editing Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Gene Editing Market Size by Country (2019-2024)

10.4 Middle East & Africa Gene Editing Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Detail

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Gene Editing Introduction

11.1.4 Thermo Fisher Scientific Revenue in Gene Editing Business (2019-2024)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 Merck

11.2.1 Merck Company Detail

11.2.2 Merck Business Overview

11.2.3 Merck Gene Editing Introduction

11.2.4 Merck Revenue in Gene Editing Business (2019-2024)

11.2.5 Merck Recent Development

11.3 Horizon Discovery

11.3.1 Horizon Discovery Company Detail

11.3.2 Horizon Discovery Business Overview

11.3.3 Horizon Discovery Gene Editing Introduction

11.3.4 Horizon Discovery Revenue in Gene Editing Business (2019-2024)

11.3.5 Horizon Discovery Recent Development

11.4 Sangamo BioSciences

11.4.1 Sangamo BioSciences Company Detail

11.4.2 Sangamo BioSciences Business Overview

11.4.3 Sangamo BioSciences Gene Editing Introduction

11.4.4 Sangamo BioSciences Revenue in Gene Editing Business (2019-2024)

11.4.5 Sangamo BioSciences Recent Development

11.5 Integrated DNA Technologies

11.5.1 Integrated DNA Technologies Company Detail

11.5.2 Integrated DNA Technologies Business Overview

11.5.3 Integrated DNA Technologies Gene Editing Introduction

11.5.4 Integrated DNA Technologies Revenue in Gene Editing Business (2019-2024)

11.5.5 Integrated DNA Technologies Recent Development

11.6 Lonza

11.6.1 Lonza Company Detail

11.6.2 Lonza Business Overview

11.6.3 Lonza Gene Editing Introduction

11.6.4 Lonza Revenue in Gene Editing Business (2019-2024)

11.6.5 Lonza Recent Development

11.7 New England Biolabs

11.7.1 New England Biolabs Company Detail

11.7.2 New England Biolabs Business Overview

11.7.3 New England Biolabs Gene Editing Introduction

11.7.4 New England Biolabs Revenue in Gene Editing Business (2019-2024)

11.7.5 New England Biolabs Recent Development

11.8 OriGene Technologies

11.8.1 OriGene Technologies Company Detail

11.8.2 OriGene Technologies Business Overview

11.8.3 OriGene Technologies Gene Editing Introduction

11.8.4 OriGene Technologies Revenue in Gene Editing Business (2019-2024)

11.8.5 OriGene Technologies Recent Development

11.9 Transposagen Biopharmaceuticals

11.9.1 Transposagen Biopharmaceuticals Company Detail

11.9.2 Transposagen Biopharmaceuticals Business Overview

11.9.3 Transposagen Biopharmaceuticals Gene Editing Introduction

11.9.4 Transposagen Biopharmaceuticals Revenue in Gene Editing Business (2019-2024)

11.9.5 Transposagen Biopharmaceuticals Recent Development

11.10 Editas Medicine

11.10.1 Editas Medicine Company Detail

11.10.2 Editas Medicine Business Overview

11.10.3 Editas Medicine Gene Editing Introduction

11.10.4 Editas Medicine Revenue in Gene Editing Business (2019-2024)

11.10.5 Editas Medicine Recent Development

11.11 CRISPR Therapeutics

11.11.1 CRISPR Therapeutics Company Detail

11.11.2 CRISPR Therapeutics Business Overview

11.11.3 CRISPR Therapeutics Gene Editing Introduction

11.11.4 CRISPR Therapeutics Revenue in Gene Editing Business (2019-2024)

11.11.5 CRISPR Therapeutics Recent Development

11.12 RGen Solutions

11.12.1 RGen Solutions Company Detail

11.12.2 RGen Solutions Business Overview

11.12.3 RGen Solutions Gene Editing Introduction

11.12.4 RGen Solutions Revenue in Gene Editing Business (2019-2024)

11.12.5 RGen Solutions Recent Development

11.13 Sigma-Aldrich

11.13.1 Sigma-Aldrich Company Detail

11.13.2 Sigma-Aldrich Business Overview

11.13.3 Sigma-Aldrich Gene Editing Introduction

11.13.4 Sigma-Aldrich Revenue in Gene Editing Business (2019-2024)

11.13.5 Sigma-Aldrich Recent Development

11.14 GeneCopoeia

11.14.1 GeneCopoeia Company Detail

11.14.2 GeneCopoeia Business Overview

11.14.3 GeneCopoeia Gene Editing Introduction

11.14.4 GeneCopoeia Revenue in Gene Editing Business (2019-2024)

11.14.5 GeneCopoeia Recent Development

11.15 Genscript Biotech

11.15.1 Genscript Biotech Company Detail

11.15.2 Genscript Biotech Business Overview

11.15.3 Genscript Biotech Gene Editing Introduction

11.15.4 Genscript Biotech Revenue in Gene Editing Business (2019-2024)

11.15.5 Genscript Biotech Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Thermo Fisher Scientific

Merck

Horizon Discovery

Sangamo BioSciences

Integrated DNA Technologies

Lonza

New England Biolabs

Transposagen Biopharmaceuticals

Editas Medicine

CRISPR Therapeutics

RGen Solutions

Sigma-aldrich

GeneCopoeia

Genscript Biotech

Origene Technologies

List of Tables

Table 1. Global Gene Editing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Zinc finger nucleases (ZFNs)

Table 3. Key Players of Transcription Activator-Like Effector-based Nucleases (TALENs)

Table 4. Key Players of CRISPR-Cas system

Table 5. Global Gene Editing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Gene Editing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Gene Editing Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Gene Editing Market Share by Region (2019-2024)

Table 9. Global Gene Editing Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Gene Editing Market Share by Region (2025-2030)

Table 11. Gene Editing Market Trends

Table 12. Gene Editing Market Drivers

Table 13. Gene Editing Market Challenges

Table 14. Gene Editing Market Restraints

Table 15. Global Gene Editing Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Gene Editing Market Share by Players (2019-2024)

Table 17. Global Top Gene Editing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Editing as of 2023)

Table 18. Ranking of Global Top Gene Editing Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Gene Editing Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Gene Editing Product Solution and Service

Table 22. Date of Enter into Gene Editing Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Gene Editing Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Gene Editing Revenue Market Share by Type (2019-2024)

Table 26. Global Gene Editing Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Gene Editing Revenue Market Share by Type (2025-2030)

Table 28. Global Gene Editing Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Gene Editing Revenue Market Share by Application (2019-2024)

Table 30. Global Gene Editing Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Gene Editing Revenue Market Share by Application (2025-2030)

Table 32. North America Gene Editing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Gene Editing Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Gene Editing Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Gene Editing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Gene Editing Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Gene Editing Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Gene Editing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Gene Editing Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Gene Editing Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Gene Editing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Gene Editing Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Gene Editing Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Gene Editing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Gene Editing Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Gene Editing Market Size by Country (2025-2030) & (US$ Million)

Table 47. Thermo Fisher Scientific Company Detail

Table 48. Thermo Fisher Scientific Business Overview

Table 49. Thermo Fisher Scientific Gene Editing Product

Table 50. Thermo Fisher Scientific Revenue in Gene Editing Business (2019-2024) & (US$ Million)

Table 51. Thermo Fisher Scientific Recent Development

Table 52. Merck Company Detail

Table 53. Merck Business Overview

Table 54. Merck Gene Editing Product

Table 55. Merck Revenue in Gene Editing Business (2019-2024) & (US$ Million)

Table 56. Merck Recent Development

Table 57. Horizon Discovery Company Detail

Table 58. Horizon Discovery Business Overview

Table 59. Horizon Discovery Gene Editing Product

Table 60. Horizon Discovery Revenue in Gene Editing Business (2019-2024) & (US$ Million)

Table 61. Horizon Discovery Recent Development

Table 62. Sangamo BioSciences Company Detail

Table 63. Sangamo BioSciences Business Overview

Table 64. Sangamo BioSciences Gene Editing Product

Table 65. Sangamo BioSciences Revenue in Gene Editing Business (2019-2024) & (US$ Million)

Table 66. Sangamo BioSciences Recent Development

Table 67. Integrated DNA Technologies Company Detail

Table 68. Integrated DNA Technologies Business Overview

Table 69. Integrated DNA Technologies Gene Editing Product

Table 70. Integrated DNA Technologies Revenue in Gene Editing Business (2019-2024) & (US$ Million)

Table 71. Integrated DNA Technologies Recent Development

Table 72. Lonza Company Detail

Table 73. Lonza Business Overview

Table 74. Lonza Gene Editing Product

Table 75. Lonza Revenue in Gene Editing Business (2019-2024) & (US$ Million)

Table 76. Lonza Recent Development

Table 77. New England Biolabs Company Detail

Table 78. New England Biolabs Business Overview

Table 79. New England Biolabs Gene Editing Product

Table 80. New England Biolabs Revenue in Gene Editing Business (2019-2024) & (US$ Million)

Table 81. New England Biolabs Recent Development

Table 82. OriGene Technologies Company Detail

Table 83. OriGene Technologies Business Overview

Table 84. OriGene Technologies Gene Editing Product

Table 85. OriGene Technologies Revenue in Gene Editing Business (2019-2024) & (US$ Million)

Table 86. OriGene Technologies Recent Development

Table 87. Transposagen Biopharmaceuticals Company Detail

Table 88. Transposagen Biopharmaceuticals Business Overview

Table 89. Transposagen Biopharmaceuticals Gene Editing Product

Table 90. Transposagen Biopharmaceuticals Revenue in Gene Editing Business (2019-2024) & (US$ Million)

Table 91. Transposagen Biopharmaceuticals Recent Development

Table 92. Editas Medicine Company Detail

Table 93. Editas Medicine Business Overview

Table 94. Editas Medicine Gene Editing Product

Table 95. Editas Medicine Revenue in Gene Editing Business (2019-2024) & (US$ Million)

Table 96. Editas Medicine Recent Development

Table 97. CRISPR Therapeutics Company Detail

Table 98. CRISPR Therapeutics Business Overview

Table 99. CRISPR Therapeutics Gene Editing Product

Table 100. CRISPR Therapeutics Revenue in Gene Editing Business (2019-2024) & (US$ Million)

Table 101. CRISPR Therapeutics Recent Development

Table 102. RGen Solutions Company Detail

Table 103. RGen Solutions Business Overview

Table 104. RGen Solutions Gene Editing Product

Table 105. RGen Solutions Revenue in Gene Editing Business (2019-2024) & (US$ Million)

Table 106. RGen Solutions Recent Development

Table 107. Sigma-Aldrich Company Detail

Table 108. Sigma-Aldrich Business Overview

Table 109. Sigma-Aldrich Gene Editing Product

Table 110. Sigma-Aldrich Revenue in Gene Editing Business (2019-2024) & (US$ Million)

Table 111. Sigma-Aldrich Recent Development

Table 112. GeneCopoeia Company Detail

Table 113. GeneCopoeia Business Overview

Table 114. GeneCopoeia Gene Editing Product

Table 115. GeneCopoeia Revenue in Gene Editing Business (2019-2024) & (US$ Million)

Table 116. GeneCopoeia Recent Development

Table 117. Genscript Biotech Company Detail

Table 118. Genscript Biotech Business Overview

Table 119. Genscript Biotech Gene Editing Product

Table 120. Genscript Biotech Revenue in Gene Editing Business (2019-2024) & (US$ Million)

Table 121. Genscript Biotech Recent Development

Table 122. Research Programs/Design for This Report

Table 123. Key Data Information from Secondary Sources

Table 124. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Gene Editing Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Gene Editing Market Share by Type: 2023 VS 2030

Figure 3. Zinc finger nucleases (ZFNs) Features

Figure 4. Transcription Activator-Like Effector-based Nucleases (TALENs) Features

Figure 5. CRISPR-Cas system Features

Figure 6. Global Gene Editing Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Gene Editing Market Share by Application: 2023 VS 2030

Figure 8. Biotechnology & Pharmaceutical Companies Case Studies

Figure 9. Academic & Government Research Institutes Case Studies

Figure 10. Contract Research Organizations Case Studies

Figure 11. Gene Editing Report Years Considered

Figure 12. Global Gene Editing Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Gene Editing Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Gene Editing Market Share by Region: 2023 VS 2030

Figure 15. Global Gene Editing Market Share by Players in 2023

Figure 16. Global Top Gene Editing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Editing as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Gene Editing Revenue in 2023

Figure 18. North America Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Gene Editing Market Share by Country (2019-2030)

Figure 20. United States Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Gene Editing Market Share by Country (2019-2030)

Figure 24. Germany Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Gene Editing Market Share by Region (2019-2030)

Figure 32. China Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Gene Editing Market Share by Country (2019-2030)

Figure 40. Mexico Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Gene Editing Market Share by Country (2019-2030)

Figure 44. Turkey Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Gene Editing Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Thermo Fisher Scientific Revenue Growth Rate in Gene Editing Business (2019-2024)

Figure 47. Merck Revenue Growth Rate in Gene Editing Business (2019-2024)

Figure 48. Horizon Discovery Revenue Growth Rate in Gene Editing Business (2019-2024)

Figure 49. Sangamo BioSciences Revenue Growth Rate in Gene Editing Business (2019-2024)

Figure 50. Integrated DNA Technologies Revenue Growth Rate in Gene Editing Business (2019-2024)

Figure 51. Lonza Revenue Growth Rate in Gene Editing Business (2019-2024)

Figure 52. New England Biolabs Revenue Growth Rate in Gene Editing Business (2019-2024)

Figure 53. OriGene Technologies Revenue Growth Rate in Gene Editing Business (2019-2024)

Figure 54. Transposagen Biopharmaceuticals Revenue Growth Rate in Gene Editing Business (2019-2024)

Figure 55. Editas Medicine Revenue Growth Rate in Gene Editing Business (2019-2024)

Figure 56. CRISPR Therapeutics Revenue Growth Rate in Gene Editing Business (2019-2024)

Figure 57. RGen Solutions Revenue Growth Rate in Gene Editing Business (2019-2024)

Figure 58. Sigma-Aldrich Revenue Growth Rate in Gene Editing Business (2019-2024)

Figure 59. GeneCopoeia Revenue Growth Rate in Gene Editing Business (2019-2024)

Figure 60. Genscript Biotech Revenue Growth Rate in Gene Editing Business (2019-2024)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions